Interim analysis from the OPTIC trial, a dose-ranging study of ponatinib for CP-CML ecancer 7:02 3 years ago 51 Далее Скачать
OPTIC: A dose-ranging study of 3 starting doses of ponatinib for chronic-phase chronic myeloid l... ecancer 6:16 4 years ago 58 Далее Скачать
An update on the OPTIC study: adjusting the dose of ponatinib for CP-CML VJHemOnc – Video Journal of Hematology & HemOnc 1:38 2 days ago 26 Далее Скачать
Dosing strategy of ponatinib in CP-CML: insights from the OPTIC trial VJHemOnc – Video Journal of Hematology & HemOnc 1:43 3 months ago 71 Далее Скачать
Jorge E Cortes ASCO20: Interim Analysis of the Phase II OPTIC Trial of Ponatinib in CP-CML Touch Medical Media 5:10 4 years ago 128 Далее Скачать
OPTIC 3-year update: dose-optimization of 3 starting doses of ponatinib in CP-CML VJHemOnc – Video Journal of Hematology & HemOnc 2:59 1 year ago 61 Далее Скачать
Dr. Matilda K. Ong'ondi on OPTIC Trial: Optimizing Ponatinib Treatment in CP-CML Best of ASCO Africa 11:31 3 years ago 35 Далее Скачать
Dose modification of ponatinib in CP-CML: data from the PACE and OPTIC trials VJHemOnc – Video Journal of Hematology & HemOnc 2:20 1 year ago 55 Далее Скачать
OPTIC: Ponatinib in chronic-phase CML VJHemOnc – Video Journal of Hematology & HemOnc 1:37 2 years ago 234 Далее Скачать
ASH 2021: New OPTIC Trial Analysis Shows Ponatinib is Effective in Chronic Myeloid Leukemia Patients CheckRare 3:31 2 years ago 391 Далее Скачать
OPTIC: ponatinib in resistant chronic-phase CML VJHemOnc – Video Journal of Hematology & HemOnc 4:19 4 years ago 273 Далее Скачать
Interim Data Analysis Suggests Ponatinib to be Favorable TKI Treatment Among CML Patients CheckRare 3:51 3 years ago 127 Далее Скачать
OPTIC post hoc analyses: OPTIC and PACE comparison & impact of mutations on ponatinib starting dose VJHemOnc – Video Journal of Hematology & HemOnc 1:35 1 year ago 29 Далее Скачать
Managing drug resistance in CP-CML with ponatinib and asciminib VJHemOnc – Video Journal of Hematology & HemOnc 1:08 9 months ago 122 Далее Скачать
Ponatinib in chronic-phase CML patients with prior second generation TKI exposure VJHemOnc – Video Journal of Hematology & HemOnc 4:44 3 years ago 314 Далее Скачать
Jorge Cortes, MD, tells us about the OPTIC study, a phase 2 investigation of ponatinib in CML OBRoncology 2:47 4 years ago 115 Далее Скачать
Outcomes of patients with CML-CP treated with ponatinib vs 2G-TKIs in the third-line setting VJHemOnc – Video Journal of Hematology & HemOnc 2:49 1 year ago 122 Далее Скачать
First-in-class STAMP inhibitor asciminib in patients with CML harbouring the T315I mutation ecancer 7:30 3 years ago 558 Далее Скачать
Jorge E Cortes, ASCO20: 5-Year Analysis of the Phase II PACE Trial of Ponatinib in Ph+ leukemia Touch Medical Media 6:36 4 years ago 58 Далее Скачать
